INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
HOUSE PTR/PurchaseVerified data

Gilbert Ray Cisneros, Jr. bought HQY

Self · HEALTHEQUITY, INC. · HealthEquity, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Jul 10, 2026
Disclosed
Sep 4, 2026
Disclosure timeline56 days from execution to publication · legal deadline 45 days
Jul 10 executedSep 4, 2026 disclosed

HQY · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
40/ 100 · ELEVATED
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing+15 / 15

    Disclosed 56 days after execution (STOCK Act deadline: 45)

  • Historical behavior+4 / 15

    2 prior trades recorded in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HQY

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    32
    RS
    Rajasekar SunilEVP Chief Prod & Strat Officer
    HQYHEALTHEQUITY, INC.
    Open-market sale
    		SELL$11K
    108 sh
    		Aug 24, 2026Oct 19, 2026
    traded Aug 24, 2026
    		+56dSEC FORM 4

    Evidence

    36
    RS
    Rajasekar SunilEVP Chief Prod & Strat Officer
    HQYHEALTHEQUITY, INC.
    Open-market sale
    		SELL$1,905
    23 sh
    		Apr 22, 2026Oct 19, 2026
    traded Apr 22, 2026
    		+180dSEC FORM 4

    Evidence

    25
    RS
    Rajasekar SunilEVP Chief Prod & Strat Officer
    HQYHEALTHEQUITY, INC.
    Open-market purchase
    		BUY$9,756
    108 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    56
    RS
    Rajasekar SunilEVP Chief Prod & Strat Officer
    HQYHEALTHEQUITY, INC.
    Open-market purchase
    		BUY$2,186
    23 sh
    		Jul 8, 2026Oct 19, 2026
    traded Jul 8, 2026
    		+103dSEC FORM 4

    Evidence

    12
    NS
    Neeleman StephenDirector, FOUNDER AND VICE CHAIRMAN
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$100K
    1,095 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    15
    LM
    Lucania James MEVP & CFO
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$257K
    2,822 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    12
    GM
    Gathright MichaelChief Customer Officer
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$60K
    662 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    12
    CS
    Cutler ScottDirector, President and CEO
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$112K
    1,230 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    12
    LD
    Ladd DelanoEVP, General Counsel
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$98K
    1,080 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    8
    FH
    Fiore Michael HenryFormer EVP, CCO
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$185K
    2,032 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    10
    FH
    Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
    HQYHEALTHEQUITY, INC.
    Open-market sale · 10b5-1 plan
    		SELL$235K
    2,470 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    25
    Gilbert Ray Cisneros, Jr.DSelf
    HQYHEALTHEQUITY, INC.
    Purchase
    		BUY$1,001 – $15KJun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dHOUSE PTR

    Evidence

    17
    MC
    McCowan Debra CharlotteDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    13
    PB
    Parker Stuart B.Director
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    21
    GW
    Gassen WilliamDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    13
    WF
    Wellborn Gayle FurgursonDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    13
    NR
    Natarajan RajeshDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    24
    Gilbert Ray Cisneros, Jr.DSelf
    HQYHEALTHEQUITY, INC.
    Purchase
    		BUY$1,001 – $15KMay 29, 2026Jun 8, 2026
    traded May 29, 2026
    		+10dHOUSE PTR

    Evidence

    15
    FH
    Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
    HQYHEALTHEQUITY, INC.
    Open-market sale · 10b5-1 plan
    		SELL$298K
    3,142 sh
    		May 29, 2026Jun 2, 2026
    traded May 29, 2026
    		+4dSEC FORM 4

    Evidence

    15
    CS
    Cutler ScottDirector, President and CEO
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$413K
    4,931 sh
    		Apr 6, 2026Apr 8, 2026
    traded Apr 6, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20035190

    Timestamps

    Event (reported)
    Jul 10, 2026
    Published
    Sep 4, 2026
    Ingested by INSIDER
    Nov 4, 22:39 UTC
    Last re-read
    Nov 5, 18:11 UTC

    Extracted facts

    Filer
    Gilbert Ray Cisneros, Jr.
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    HealthEquity, Inc. - Common Stock
    Ticker
    HQY
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Jul 10, 2026
    Notification date (reported)
    Aug 14, 2026
    Days from execution to publication
    56

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Gilbert Ray Cisneros, Jr. reported a purchase of HealthEquity, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Gilbert Ray Cisneros, Jr.bioguide:C001123
    Issuer
    HEALTHEQUITY, INC.cik:0001428336

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.